• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

lichenicidin 合理定点突变文库:一种用于生成生物工程类细菌素的工具。

Lichenicidin rational site-directed mutagenesis library: A tool to generate bioengineered lantibiotics.

机构信息

Department of Biology & Centre for Environmental and Marine Studies (CESAM), University of Aveiro, Aveiro, Portugal.

Institut für Chemie, Technical University of Berlin, Berlin, Germany.

出版信息

Biotechnol Bioeng. 2019 Nov;116(11):3053-3062. doi: 10.1002/bit.27130. Epub 2019 Aug 8.

DOI:10.1002/bit.27130
PMID:31350903
Abstract

Lantibiotics are ribosomally synthesized and posttranslationally modified antimicrobial peptides that arise as an alternative to the traditional antibiotics. Lichenicidin is active against clinically relevant bacteria and it was the first lantibiotic to be fully produced in vivo in the Gram-negative host Escherichia coli. Here, we present the results of a library of lichenicidin mutants, in which the mutations were generated based on the extensive bibliographical search available for other lantibiotics. The antibacterial activity of two-peptide lantibiotics, as is lichenicidin, requires the synergistic activity of two peptides. We established a method that allows screening for bioactivity which does not require the purification of the complementary peptide. It is an inexpensive, fast and user-friendly method that can be scaled up to screen large libraries of bioengineered two-peptide lantibiotics. The applied system is reliable and robust because, in general, the results obtained corroborate structure-activity relationship studies carried out for other lantibiotics.

摘要

类杆菌素是核糖体合成和翻译后修饰的抗菌肽,是传统抗生素的替代品。地衣芽孢菌素对临床相关细菌具有活性,它是第一个在革兰氏阴性宿主大肠杆菌中体内完全产生的类杆菌素。在这里,我们展示了一个类杆菌素突变体文库的结果,其中的突变是基于其他类杆菌素的广泛文献搜索生成的。两肽类杆菌素(如地衣芽孢菌素)的抗菌活性需要两种肽的协同作用。我们建立了一种筛选方法,该方法不需要纯化互补肽就能检测生物活性。它是一种廉价、快速且用户友好的方法,可以扩展到筛选大量生物工程两肽类杆菌素文库。所应用的系统是可靠和强大的,因为一般来说,获得的结果与针对其他类杆菌素进行的结构-活性关系研究相符。

相似文献

1
Lichenicidin rational site-directed mutagenesis library: A tool to generate bioengineered lantibiotics.lichenicidin 合理定点突变文库:一种用于生成生物工程类细菌素的工具。
Biotechnol Bioeng. 2019 Nov;116(11):3053-3062. doi: 10.1002/bit.27130. Epub 2019 Aug 8.
2
Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli.地衣芽孢杆菌II型羊毛硫抗生素在大肠杆菌中的异源表达、生物合成及诱变
Chem Biol. 2011 Jan 28;18(1):90-100. doi: 10.1016/j.chembiol.2010.11.010.
3
Bioengineering of lanthipeptides in Escherichia coli: assessing the specificity of lichenicidin and haloduracin biosynthetic machinery.大肠杆菌中羊毛硫肽的生物工程:评估地衣素和嗜盐菌素生物合成机制的特异性
Res Microbiol. 2014 Sep;165(7):600-4. doi: 10.1016/j.resmic.2014.07.006. Epub 2014 Jul 21.
4
Engineering the heterologous expression of lanthipeptides in Escherichia coli by multigene assembly.通过多基因组装在大肠杆菌中构建羊毛硫肽的异源表达。
Appl Microbiol Biotechnol. 2015 Aug;99(15):6351-61. doi: 10.1007/s00253-015-6557-6. Epub 2015 Apr 7.
5
Lichenicidin biosynthesis in Escherichia coli: licFGEHI immunity genes are not essential for lantibiotic production or self-protection.在大肠杆菌中合成lichenicidin:lichenicin 的 FGEHI 免疫基因对于抗生素的产生或自我保护并非必需。
Appl Environ Microbiol. 2011 Jul;77(14):5023-6. doi: 10.1128/AEM.00270-11. Epub 2011 May 20.
6
Assessing the potential of the two-peptide lantibiotic lichenicidin as a new generation antimicrobial.评估双肽类羊毛硫抗生素岩藻素作为新一代抗菌剂的潜力。
World J Microbiol Biotechnol. 2022 Jan 3;38(1):18. doi: 10.1007/s11274-021-03196-y.
7
Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.提高基于乳链菌肽的类细菌素对革兰氏阴性病原体的抗菌活性。
Appl Environ Microbiol. 2018 May 31;84(12). doi: 10.1128/AEM.00052-18. Print 2018 Jun 15.
8
Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.对双组分羊毛硫抗生素乳酸乳球菌素3147进行全丙氨酸扫描:为合理药物设计绘制蓝图。
Mol Microbiol. 2006 Nov;62(3):735-47. doi: 10.1111/j.1365-2958.2006.05398.x.
9
Lantibiotics: promising candidates for future applications in health care.类细菌素:未来在医疗保健中应用的有前景的候选物。
Int J Med Microbiol. 2014 Jan;304(1):51-62. doi: 10.1016/j.ijmm.2013.09.003. Epub 2013 Sep 4.
10
Roseocin, a novel two-component lantibiotic from an actinomycete.玫瑰菌素,一种新型放线菌两组分类细菌素。
Mol Microbiol. 2020 Feb;113(2):326-337. doi: 10.1111/mmi.14419. Epub 2019 Nov 27.

引用本文的文献

1
Heterologous Expression and Characterization of Estercin A, a Class II Lanthipeptide Derived from CF016, with Antimicrobial Activity against Clinically Relevant Pathogens.来自CF016的具有抗临床相关病原菌活性的II类羊毛硫肽A酯菌素A的异源表达与特性分析
J Nat Prod. 2025 Feb 28;88(2):262-273. doi: 10.1021/acs.jnatprod.4c00814. Epub 2025 Jan 15.
2
Metagenomics reveals the habitat specificity of biosynthetic potential of secondary metabolites in global food fermentations.宏基因组学揭示了全球食品发酵中次生代谢物生物合成潜力的生境特异性。
Microbiome. 2023 May 20;11(1):115. doi: 10.1186/s40168-023-01536-8.
3
Phylogeny-guided genome mining of roseocin family lantibiotics to generate improved variants of roseocin.
基于系统发育学指导的玫瑰霉素家族羊毛硫抗生素基因组挖掘,以生成玫瑰霉素的改良变体。
AMB Express. 2023 Mar 20;13(1):34. doi: 10.1186/s13568-023-01536-9.
4
Class II two-peptide lanthipeptide proteases: exploring LicTP for biotechnological applications.II 类双肽类蓝细菌肽酶:探索 LicTP 用于生物技术应用。
Appl Microbiol Biotechnol. 2023 Mar;107(5-6):1687-1696. doi: 10.1007/s00253-023-12388-5. Epub 2023 Feb 10.
5
Specific Binding of the α-Component of the Lantibiotic Lichenicidin to the Peptidoglycan Precursor Lipid II Predetermines Its Antimicrobial Activity.兰尼丁类抗生素的 α-组分与肽聚糖前体脂质 II 的特异性结合决定了其抗菌活性。
Int J Mol Sci. 2023 Jan 10;24(2):1332. doi: 10.3390/ijms24021332.
6
Assessing the potential of the two-peptide lantibiotic lichenicidin as a new generation antimicrobial.评估双肽类羊毛硫抗生素岩藻素作为新一代抗菌剂的潜力。
World J Microbiol Biotechnol. 2022 Jan 3;38(1):18. doi: 10.1007/s11274-021-03196-y.
7
Bio-Engineered Nisin with Increased Anti- and Selectively Reduced Anti- Activity for Treatment of Bovine Mastitis.具有增强的抗和选择性降低的抗活性的生物工程乳链菌肽用于治疗牛乳腺炎。
Int J Mol Sci. 2021 Mar 27;22(7):3480. doi: 10.3390/ijms22073480.
8
Combating Antimicrobial Resistance With New-To-Nature Lanthipeptides Created by Genetic Code Expansion.利用遗传密码扩展产生的新型天然羊毛硫肽对抗抗菌素耐药性。
Front Microbiol. 2020 Nov 5;11:590522. doi: 10.3389/fmicb.2020.590522. eCollection 2020.